Twist Bioscience Corporation
TWST
$25.31
-$0.30-1.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.91% | 23.23% | 24.08% | 26.53% | 27.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.91% | 23.23% | 24.08% | 26.53% | 27.81% |
| Cost of Revenue | -3.10% | 5.28% | 7.85% | 9.55% | 10.39% |
| Gross Profit | 45.44% | 49.04% | 47.92% | 55.91% | 61.09% |
| SG&A Expenses | 11.58% | 14.47% | 6.32% | 12.14% | 23.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.57% | 8.18% | 4.12% | 6.33% | 11.59% |
| Operating Income | 31.53% | 14.99% | 26.25% | 22.68% | 9.65% |
| Income Before Tax | 124.11% | 13.28% | 26.56% | 25.21% | -50.39% |
| Income Tax Expenses | 0.00% | -49.28% | -19.17% | 56.76% | -69.29% |
| Earnings from Continuing Operations | 123.83% | 13.55% | 26.54% | 25.06% | -49.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 123.83% | 13.55% | 26.54% | 25.06% | -49.09% |
| EBIT | 31.53% | 14.99% | 26.25% | 22.68% | 9.65% |
| EBITDA | 32.60% | 13.38% | 27.17% | 18.01% | 11.22% |
| EPS Basic | 123.10% | 16.26% | 28.61% | 26.69% | -46.26% |
| Normalized Basic EPS | 32.27% | 16.01% | 28.64% | 20.88% | 11.19% |
| EPS Diluted | 122.42% | 16.26% | 28.61% | 26.69% | -46.26% |
| Normalized Diluted EPS | 33.58% | 16.01% | 28.64% | 20.88% | 11.19% |
| Average Basic Shares Outstanding | 3.18% | 3.24% | 2.90% | 2.23% | 1.94% |
| Average Diluted Shares Outstanding | 5.19% | 3.24% | 2.90% | 2.23% | 1.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |